Market Overview

UPDATE: Novartis Posts Rise In Q4 Profit

Related NVS
Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers
A District Court's Ruling Against Teva Pharma Opens The Door For Generics
Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug (Investor's Business Daily)

Novartis AG (NYSE: NVS) reported a rise in its net profit in the fourth quarter.

Novartis' quarterly net profit surged to $2.05 billion, versus $1.18 billion, in the year-ago period. However, analysts were expecting a profit of $2.38 billion.

Its net sales came in at $14.83 billion.

Novartis shares closed at $65.13 yesterday.

Posted-In: profitEarnings News


Related Articles (NVS)

View Comments and Join the Discussion!